Search clinical trials for: (C) zidovudine, didanosine, and nevirapine

Total 3563 results

Peking Union Medical College
Ministry of Science and Technology of the People´s Republic of China

Completed

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort

HIV Infections

China
Harvard School of Public Health (HSPH)
Bristol-Myers Squibb; McGill University Health Centre/Research Institute of... and other collaborators

Completed

The Adult Antiretroviral Treatment and Resistance Study (Tshepo)

HIV Infection | AIDS

Botswana
Johns Hopkins Bloomberg School of Public Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission

HIV Infections

Malawi
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Terminated

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

HIV Infections

Kenya
Elim Pediatric Pharmaceuticals Inc.

Unknown

Bioequivalence Study of Pediatric Formulations to Treat HIV Infection

HIV | AIDS

Nigeria
Institut de Recherche pour le Developpement

Completed

One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

HIV Infections

Thailand
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease

HIV Infections

United States, Puerto Rico
Washington University School of Medicine

Completed

Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV (ARMAM)

HIV | Severe Acute Malnutrition | Kwashiorkor | Marasmus

Malawi
Boehringer Ingelheim

Completed

A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)

Acquired Immunodeficiency Syndrome

South Africa
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

HIV Infections

United States, Puerto Rico
University of Washington
Elizabeth Glaser Pediatric AIDS Foundation

Completed

ARVs to Prevent Breastmilk HIV:Viral and Immune Responses

HIV Infections

Kenya
Tuberculosis Research Centre, India
Indian Council of Medical Research; National AIDS Control Organisation

Unknown

Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment

Tuberculosis | Human Immunodeficiency Virus Infections

India
The HIV Netherlands Australia Thailand Research...
Khon Kaen University

Active, not recruiting

A Prospective Cohort of Children With HIV Infection

HIV Infections

Thailand
Institut de Recherche pour le Developpement
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers (PHPT-5)

HIV Infections

Thailand
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

HIV Infections

Thailand
National Cancer Institute (NCI)

Completed

A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine

Acquired Immunodeficiency Syndrome | AIDS-Related Complex

United States
Institut de Recherche pour le Developpement
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Terminated

Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand (PHPT-5)

HIV Infections | Pregnancy

Thailand
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries (PROMISE)

HIV Infections

Malawi, South Africa, Tanzania, Zimbabwe, India, Uganda, Zambia
National Institute of Allergy and Infectious Diseases...

Completed

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

HIV Infections

United States, Puerto Rico
Bristol-Myers Squibb

Completed

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

HIV Infections

United States, Canada
Centers for Disease Control and Prevention
University of North Carolina, Chapel Hill; Kamuzu Central Hospital

Completed

Breastfeeding, Antiretroviral, and Nutrition Study

HIV Infections

Malawi
Centers for Disease Control and Prevention

Unknown

A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding (KiBS)

HIV Infections

Kenya
University of California, San Diego
National Institute of Mental Health (NIMH); Peking University; Beijing YouAn... and other collaborators

Completed

Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China

HIV Infections | Central Nervous System Diseases | Dementia

China
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV

HIV Infections

United States, Puerto Rico
National Cancer Institute (NCI)

Completed

A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection

HIV Infections

United States
Glaxo Wellcome

Completed

A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
National Cancer Institute (NCI)

Completed

A Study of Azidothymidine in HIV-Infected Children

HIV Infections | Encephalopathies

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

HIV Infections

United States, Puerto Rico, Italy
Bristol-Myers Squibb

Completed

Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb

Completed

A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

HIV Infections | Pregnancy

United States, Puerto Rico, Brazil, Bahamas
National Institute of Allergy and Infectious Diseases...

Completed

The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients

HIV Infections

United States
University of British Columbia
Boehringer Ingelheim; Abbott; CIHR Canadian HIV Trials Network

Completed

NRTI-Sparing Pilot Study

HIV | Mitochondrial Toxicity

Canada
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex

HIV Infections | AIDS Dementia Complex

United States
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb

Completed

Comparison of ddI Versus Zidovudine in HIV-Infected Patients

HIV Infections

United States, Puerto Rico
Boehringer Ingelheim

Completed

Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive Women

HIV Infections
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

Evaluation of Patients Who Have Not Had Success With Zidovudine

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

HIV Infections

United States
Amsterdam UMC, location VUmc
Boehringer Ingelheim; Abbott

Unknown

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

HIV Infections | HIV-Associated Lipodystrophy Syndrome

Finland, Netherlands, Spain, United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb

Completed

The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past

HIV Infections

United States, Tanzania, Puerto Rico
Glaxo Wellcome

Completed

The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease

HIV Infections

United States, Puerto Rico, Australia
Boehringer Ingelheim

Completed

A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.

HIV Infections

United States, Botswana, Germany, South Africa

Search clinical trials for: (C) zidovudine, didanosine, and nevirapine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations